Mitchell P. Rales - 10 Jun 2026 Form 4 Insider Report for ESAB Corp (ESAB)

Reporting relationship: Executive Chair of Board, Director
Issuer ticker: ESAB
Reported as of: 10 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2026, 16:30:09 UTC
Prior SEC filing: 02 Jun 2026
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Mitchell P. Rales

Key filing fact

Mitchell P. Rales filed Form 4 for ESAB Corp (ESAB) on 12 Jun 2026.

Key facts

This page summarizes Mitchell P. Rales's Form 4 filing for ESAB Corp (ESAB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Jun 2026, 16:30.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001015014 Primary reporting owner

RALES MITCHELL P

Relationship: Executive Chair of Board, Director
Address: 11790 GLEN ROAD, POTOMAC
Signature: /s/ Mitchell P. Rales
Signature date: 12 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ESAB transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +1,200,000
Change %
Price: $0.000000^*
Shares after: 1,200,000
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Common stock, par value $0.001
Underlying amount: 1,200,000
Exercise price: $82.92
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 10, 2026, the Issuer granted to the Reporting Person a performance stock option in connection with his appointment as Executive Chair of the Board of the Issuer. The option becomes exercisable, if at all, in three tranches subject to (A) the simple average closing prices of the Issuer's common stock on the NYSE during any 30-trailing day period exceeding certain stock price hurdles during the four-year period commencing on the second anniversary of the grant date and ending on the sixth anniversary of the grant date and (B) the Reporting Person's continued employment with the Issuer through the later of the fourth, fifth and sixth anniversary of the grant date, respectively, and the Company's certification of achievement of a stock price hurdle.